Literature DB >> 21343349

High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology.

Ashraful Haque1, Shannon E Best, Fiona H Amante, Anne Ammerdorffer, Fabian de Labastida, Tamara Pereira, Grant A Ramm, Christian R Engwerda.   

Abstract

Infection of C57BL/6 mice with Plasmodium berghei ANKA induces a fatal neurological disease commonly referred to as experimental cerebral malaria. The onset of neurological symptoms and mortality depend on pathogenic CD8(+) T cells and elevated parasite burdens in the brain. Here we provide clear evidence of liver damage in this model, which precedes and is independent of the onset of neurological symptoms. Large numbers of parasite-specific CD8(+) T cells accumulated in the liver following P. berghei ANKA infection. However, systemic depletion of these cells at various times during infection, while preventing neurological symptoms, failed to protect against liver damage or ameliorate it once established. In contrast, rapid, drug-mediated removal of parasites prevented hepatic injury if administered early and quickly resolved liver damage if administered after the onset of clinical symptoms. These data indicate that CD8(+) T cell-mediated immune pathology occurs in the brain but not the liver, while parasite-dependent pathology occurs in both organs during P. berghei ANKA infection. Therefore, we show that P. berghei ANKA infection of C57BL/6 mice is a multiorgan disease driven by the accumulation of parasites, which is also characterized by organ-specific CD8(+) T cell-mediated pathology.

Entities:  

Mesh:

Year:  2011        PMID: 21343349      PMCID: PMC3088131          DOI: 10.1128/IAI.01210-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology.

Authors:  Jean Langhorne; Stuart J Quin; Latifu A Sanni
Journal:  Chem Immunol       Date:  2002

2.  Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria.

Authors:  Phillipe R Bauer; Henri C Van Der Heyde; Guang Sun; Robert D Specian; D Neil Granger
Journal:  Microcirculation       Date:  2002-12       Impact factor: 2.628

3.  Role of ICAM-1 (CD54) in the development of murine cerebral malaria.

Authors:  N Favre; C Da Laperousaz; B Ryffel; N A Weiss; B A Imhof; W Rudin; R Lucas; P F Piguet
Journal:  Microbes Infect       Date:  1999-10       Impact factor: 2.700

4.  Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism.

Authors:  K Adachi; H Tsutsui; S Kashiwamura; E Seki; H Nakano; O Takeuchi; K Takeda; K Okumura; L Van Kaer; H Okamura; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Role of CD40-CVD40L in mouse severe malaria.

Authors:  P F Piguet; C D Kan; C Vesin; A Rochat; Y Donati; C Barazzone
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.

Authors:  Elodie Belnoue; Michèle Kayibanda; Ana M Vigario; Jean-Christophe Deschemin; Nico van Rooijen; Mireille Viguier; Georges Snounou; Laurent Rénia
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

7.  Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.

Authors:  Louise M Randall; Fiona H Amante; Karli A McSweeney; Yonghong Zhou; Amanda C Stanley; Ashraful Haque; Malcolm K Jones; Geoff R Hill; Glen M Boyle; Christian R Engwerda
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

8.  Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice.

Authors:  Keishi Adachi; Hiroko Tsutsui; Ekihiro Seki; Hiroki Nakano; Kazuyoshi Takeda; Ko Okumura; Luc Van Kaer; Kenji Nakanishi
Journal:  Int Immunol       Date:  2004-04-13       Impact factor: 4.823

9.  CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria.

Authors:  Thomas Jacobs; Tanja Plate; Iris Gaworski; Bernhard Fleischer
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

10.  VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis.

Authors:  Amanda C Stanley; Jane E Dalton; Susanna H Rossotti; Kelli P MacDonald; Yonghong Zhou; Fabian Rivera; Wayne A Schroder; Asher Maroof; Geoff R Hill; Paul M Kaye; Christian R Engwerda
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

View more
  30 in total

1.  Depletion of Phagocytic Cells during Nonlethal Plasmodium yoelii Infection Causes Severe Malaria Characterized by Acute Renal Failure in Mice.

Authors:  Mohamad Alaa Terkawi; Maki Nishimura; Hidefumi Furuoka; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2016-01-11       Impact factor: 3.441

2.  Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model.

Authors:  Siyu Xiao; Jinfeng Liu; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

3.  The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice.

Authors:  Patrice N Mimche; Lauren M Brady; Christian F Bray; Choon M Lee; Manoj Thapa; Thayer P King; Kendra Quicke; Courtney D McDermott; Sylvie M Mimche; Arash Grakoui; Edward T Morgan; Tracey J Lamb
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

4.  Type I Interferon Transcriptional Signature in Neutrophils and Low-Density Granulocytes Are Associated with Tissue Damage in Malaria.

Authors:  Douglas Taylor Golenbock; Ricardo Tostes Gazzinelli; Bruno Coelho Rocha; Pedro Elias Marques; Fabiana Maria de Souza Leoratti; Caroline Junqueira; Dhelio Batista Pereira; Lis Ribeiro do Valle Antonelli; Gustavo Batista Menezes
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

Review 5.  Imaging Plasmodium immunobiology in the liver, brain, and lung.

Authors:  Ute Frevert; Adéla Nacer; Mynthia Cabrera; Alexandru Movila; Maike Leberl
Journal:  Parasitol Int       Date:  2013-09-27       Impact factor: 2.230

6.  Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Authors:  Fatima Brant; Aline S Miranda; Lisia Esper; David Henrique Rodrigues; Lucas Miranda Kangussu; Daniella Bonaventura; Frederico Marianetti Soriani; Vanessa Pinho; Danielle G Souza; Milene Alvarenga Rachid; Louis M Weiss; Herbert B Tanowitz; Mauro Martins Teixeira; Antônio Lucio Teixeira; Fabiana Simão Machado
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

7.  Association of heme oxygenase 1 with the restoration of liver function after damage in murine malaria by Plasmodium yoelii.

Authors:  Sumanta Dey; Somnath Mazumder; Asim Azhar Siddiqui; M Shameel Iqbal; Chinmoy Banerjee; Souvik Sarkar; Rudranil De; Manish Goyal; Samik Bindu; Uday Bandyopadhyay
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

8.  Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.

Authors:  Noah S Butler; Nathan W Schmidt
Journal:  Hepatology       Date:  2015-05-26       Impact factor: 17.425

Review 9.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

10.  Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.

Authors:  Jannike Blank; Jochen Behrends; Thomas Jacobs; Bianca E Schneider
Journal:  Infect Immun       Date:  2015-12-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.